Skip to main content

D. E. Shaw & Co., Inc.

Position in GRAL — GRAIL, Inc.

CIK 1009207 New York, NY

Position in GRAL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,926,282
+$3,708,885 QoQ
Shares Held
116,102
+42.3% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Jun 30, 2026
CallValue
$232,118
CallShares
3,400
PutValue
$3,072,150
PutShares
45,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. GRAL ranks #17 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $232,118 3,400
2026-06-30 $3,072,150 45,000
2026-06-30 $7,926,282 116,102
2026-03-31 $2,325,600 45,000
2026-03-31 $496,128 9,600
2026-03-31 $4,217,397 81,606
2025-12-31 $3,447,564 40,280
2025-12-31 $4,330,854 50,600
2025-12-31 $10,279,359 120,100
2025-09-30 $2,334,451 39,480
2025-09-30 $4,819,095 81,500
2025-09-30 $331,128 5,600
2025-06-30 $287,952 5,600
2025-06-30 $6,988,645 135,913
2025-06-30 $3,892,494 75,700
2025-03-31 $6,851,922 268,282
2025-03-31 $615,514 24,100
2024-12-31 $288,456 16,160
2024-09-30 $229,626 16,688
2024-06-30 $292,890 19,056
2024-06-30 $1,059,085 68,906